Mercy Gohil

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.7K citations · Full text

T Cell Therapy, Cancer Immunosurveillance, Chronic Lymphocytic Leukemia +6

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 829 citations · Full text

Cd19-targeted T Cells, Cancer Immunosurveillance, Immunology +8

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung et al. · Nature Medicine · 2022 · 455 citations · Full text

Urology, Cancer Immunosurveillance, Genitourinary Cancer +6

The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation

Shannon A. Carty, Mercy Gohil, Lauren B. Banks et al. · The Journal of Immunology · 2017 · 161 citations · Full text

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech et al. · Immunity · 2023 · 151 citations · Full text